Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Return on Sales (2023 - 2026)

Camp4 Therapeutics' Return on Sales history spans 3 years, with the latest figure at 0.35% for Q4 2025.

  • On a quarterly basis, Return on Sales fell 14.0% to 0.35% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.14%, a 65.0% increase, with the full-year FY2025 number at 0.14%, up 65.0% from a year prior.
  • Return on Sales hit 0.35% in Q4 2025 for Camp4 Therapeutics, down from 0.17% in the prior quarter.
  • Over the last five years, Return on Sales for CAMP hit a ceiling of 0.08% in Q2 2025 and a floor of 1.42% in Q2 2024.
  • Historically, Return on Sales has averaged 0.39% across 3 years, with a median of 0.2% in 2024.
  • The widest YoY moves for Return on Sales: up 133bps in 2025, down -14bps in 2025.
  • Tracing CAMP's Return on Sales over 3 years: stood at 0.33% in 2023, then skyrocketed by 39bps to 0.2% in 2024, then crashed by -70bps to 0.35% in 2025.
  • Business Quant data shows Return on Sales for CAMP at 0.35% in Q4 2025, 0.17% in Q3 2025, and 0.08% in Q2 2025.